维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Winer ES"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma 显示文摘	Castillo J J Winer ES Stachurski D	2010	Leuk Lymphoma2010，51，11：	1
2	Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors:a randomized phase I study显示文摘	Winer ES Safran H Karaszewska B	2015	Cancer Med2015，4，1：	1
3	Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database显示文摘	Castillo J J Winer ES Olszewski AJ	2013	Am J Hematol2013，10，：	1
4	Clinical and pathological differences between human immunodeficiency viruspositive and human immunodeficiency virus-negative patients with plasmablastic lymphoma显示文摘	Castillo JJ Winer ES Stachurski D	2010	Leuk Lymphoma2010，51，11：	1
5	CAL-101:a phosphatidylinositol-3-kinase p 110-delta inhibitor for the treatment of lymphoid malignancies显示文摘	Castillo J J Furman M Winer ES	2012	Expert Opin Investig Drugs2012，21，1：	1
6	Clinical and pathological differences between human immunodeficieney virus- positive and human immunodefieieney virus-negative patients with plasmablastie lymphoma显示文摘	Castillo JJ Winer ES Staehurski D	2010	Leuk Lymphoma2010，51，11：	1
7	Prognostic factors in chemotherapy- treated patients with HIV- associated plasma- blastic lymphoma 显示文摘	Castillo JJ Winer ES Stachurski D	2010	Oncologist2010，15，：	1
8	HIV-negative plasmablastic lymphoma:not in the mouth显示文摘	Castillo JJ Winer ES Stachurski D	2011	Clin Lymphoma Myeloma Leuk2011，11，2：	1
9	Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma显示文摘	Castillo JJ Winer ES Stachurski D	2010	Leuk Lymphomas2010，51，11：	1
10	CAL - 101 : A phosphatidylinositol - 3 - kinase p110 - delta inhibitor for the treatment of lymphoid malignancies显示文摘	Castillo J J Furman M Winer ES	2012	Expert Opin Inv Drug2012，21，1：	1
11	HIV-negative plasmablastic lymphoma: not in the mouth显示文摘	Castillo JJ Winer ES Stachurski D	2011	Clin Lymphoma Myeloma Leuk2011，11，2：	1
12	Clinical and pathologi-cal differences between human immunodeficiency virus-positiveand human immunodeficiency virus-negative patients with plas-mablastic lymphoma显示文摘	Castillo JJ Winer ES Stachurski D	2010	Leuk Lymphoma2010，51，11：	1
13	Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma显示文摘	Castillo J J Winer ES Stachurski D	2010	Leuk Lymphoma2010，51，11：	1
14	HIV-negativeplasmablastic lymphoma:not in the mouth显示文摘	Castillo JJ Winer ES Stachurski D etal	2011	Clin LymphomaMyeloma Leuk2011，11，2：	1
15	CAL-101: a phos- phatidylinositol-3-kinase p110-delta inhibitor for the treat- ment of lymphoid malignancies 显示文摘	Castillo JJ Furman M Winer ES	2012	Expert Opin Investig Drugs2012，21，1：	1
16	Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma显示文摘	Castillo JJ Winer ES Stachurski D	2010	Oncologist2010，15，3：	1
17	Cloning, characterization, and genetic mapping of the rat type 2 angiotensin II receptor gene显示文摘	Koike G Winer ES Horiuchi M	1995	Hypertension1995，26，6：	1
18	PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies显示文摘	Winer ES Ingham RR CastilloJ J	2012	Expert Opin Investig Drugs2012，21，3：	1
19	Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma显示文摘	Castillo J J Winer ES Stachurski D	2010	Leukemia & Lymphoma2010，51，11：	1
20	HIV-negative plasma- blastic lymphoma: not in the mouth显示文摘	Castillo JJ Winer ES Stachurski D	2011	Clin Lymphoma Myelo- ma Leuk2011，11，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示